Tokio Marine · Insurance-Linked Funds

Janus Henderson Glb Life Sciences Acc SGD-H

Equity · Healthcare Sector Equity · SGD

SGD 18.51

Price / NAV · 2026-08-28

9.0%

YTD

31.1%

1Y Ret.

10.2%

3Y Ann.

Identifiers

ISINIE00BJT1NW94

TickerBAAS

InsurerTokio Marine

CurrencySGD

Costs & Size

Expense Ratio2.41%

Yield0.00%

AUM$5.0B

Price sourceTokio Marine fund centre

Ratings & Risk

Morningstar ratingNo Morningstar rating for this share class

Insurer risk bandAggressive (4/4)

3Y volatility15.76%

CategoryHealthcare Sector Equity

Fund Overview

as at 2026-05-31

Country exposure

United States88.3%

United Kingdom4.4%

Switzerland2.8%

France1.8%

Israel1.3%

Belgium0.7%

Canada0.4%

Japan0.3%

Ireland0.0%

Sector allocation

Healthcare100.0%

Top holdings

Eli Lilly And Co9.7%

Johnson & Johnson6.8%

Unitedhealth Group Inc4.2%

Astrazeneca Plc4.2%

Abbvie Inc3.9%

Revolution Medicines Inc Ordinary Shares3.1%

Novartis Ag Adr2.7%

Argenx Se Adr2.6%

Praxis Precision Medicines Inc Ordinary Shares2.4%

Thermo Fisher Scientific Inc2.4%

Asset mix

Stock96.2%

Other3.0%

Cash0.9%

Composition is reported less often than price and may lag it by several weeks.

Tokio Marine funds show the insurer's own published unit price. FWD funds show the underlying fund's NAV, which differs from an insurer's unit price by their charges. Every price carries its valuation date.